Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18-fluorodeoxyglucose

被引:0
作者
Yuji Nakamoto
Tsuneo Saga
Tatsuya Higashi
Takayoshi Ishimori
Hisataka Kobayashi
Koichi Ishizu
Noriko Sato
Marcelo Mamede
Harumi Sakahara
Masayuki Imamura
Junji Konishi
机构
[1] Kyoto University,Department of Nuclear Medicine and Diagnostic Imaging, Graduate School of Medicine
[2] Hamamatsu University School of Medicine,Department of Radiology
[3] Kyoto University,Department of Surgery and Surgical Basic Science, Graduate School of Medicine
[4] Institute of Biomedical Research and Innovation,Department of Image
来源
Annals of Nuclear Medicine | 2003年 / 17卷
关键词
FDG; PET; pancreatic cancer; optimal scan time;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: Image interpretation in positron emission tomography (PET) using F-18-fluoro-2-deoxy-d-glucose (FDG) is usually performed for images obtained at 1 h postinjection (PI) of FDG, but it remains unknown whether this is the optimal time for imaging patients with pancreatic disease. The aim of this study was to assess the optimal scan time for FDG-PET for patients suspected of having pancreatic cancer.Patients and Methods: Forty-four patients with suspected pancreatic cancer underwent FDG-PET scans at both 1 h and 2 h PI. Tracer uptake in the pancreatic lesions and possible liver metastasis was interpreted qualitatively, using a 5-point grading system (0 = normal, 1 = probably normal, 2 = equivocal, 3 = probably abnormal, and 4 = definitely abnormal) by 4 nuclear medicine physicians independently, who were blind to all clinical information. Detection performance with each image was compared using receiver operating characteristic (ROC) analysis. An average score of the 4 readers for each patient was also defined as consensus average index (CAI) and compared between the two images.Results: ROC results indicated no significant differences in detection performance (Averaged areas under ROC curves of 1 h vs. 2 h were 0.92 vs. 0.90 for primary tumor, and 0.81 vs. 0.85 for liver metastases). There were no significant differences in CAIs between 1 h and 2 h PI images in interpreting primary tumor and positive liver metastases, but a significant difference was observed for cases without liver metastases (p<0.05).Conclusions: The certainty of excluding liver metastases was increased when the 2h image was used, although ROC analysis did not establish a difference between 1 h and 2 h imaging for differentiating malignant and benign lesions in primary pancreatic cancer or its liver metastases.
引用
收藏
页码:421 / 426
页数:5
相关论文
共 94 条
[1]  
Delbeke D(1999)Oncological applications of FDG PET imaging J Nucl Med 40 1706-1715
[2]  
Higashi T(1997)Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study J Nucl Med 38 1337-1344
[3]  
Tamaki N(1997)Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma J Nucl Med 38 1344-1348
[4]  
Honda T(1994)F-18 fluorodeoxyglucose PET Radiology 192 79-86
[5]  
Torizuka T(1995) evaluation of pancreatic glucose metabolism for detection of pancreatic cancer Radiology 195 345-352
[6]  
Kimura T(1997)Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US Eur J Nucl Med 24 678-682
[7]  
Inokuma T(1999)Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases J Nucl Med 40 1784-1791
[8]  
Reske SN(1999)Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma Anticancer Res 19 2437-2442
[9]  
Grillenberger KG(1999)18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma J Nucl Med 40 1424-1433
[10]  
Glatting G(2000)Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET Br J Cancer 83 287-293